|
Market Closed -
Nasdaq
00:00:01 20/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.620 USD | +1.16% |
|
+0.77% | -11.19% |
| 08-18 | Cellectar Biosciences, Inc. - Special Call | |
| 08-13 | Cellectar Biosciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- CLRB Stock
- Consensus Cellectar Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
